Scott M. Wunsch, CEO of Logistics at Strata Critical Medical, Inc. (NASDAQ:SRTA), filed a Form 4 on October 30, 2026, reporting multiple acquisitions of Class A common stock and one disposition related to tax withholding, covering transactions dated July 30, 2026 and October 28, 2026.

Key Highlights

  • RSU grants on July 30, 2026: Wunsch received 9,787 RSUs vesting September 8, 2026, and 2,658 RSUs vesting December 8, 2026, both at $0 price and both representing quarterly commission program awards.
  • PSU settlement on October 28, 2026: Two separate acquisitions of 57,173 shares each were reported upon Compensation Committee certification of performance criteria for a PSU award originally granted March 20, 2025, both at $0 price.
  • Additional RSU grant: 1,416 RSUs vesting March 8, 2027, at $0 price, also under the quarterly commission program, were reported as of October 28, 2026.
  • Tax withholding disposition: 44,996 shares were withheld by the issuer at $4.76 per share to satisfy tax withholding obligations connected to the PSU vesting.
  • Resulting direct ownership: Following all reported transactions, Wunsch directly held 746,254 shares of Class A common stock.
  • Indirect ownership: An additional 382,987 shares are held indirectly through a limited liability company of which Wunsch is the sole member, according to the filing.

Scott Wunsch's October 2026 Share Activity at Strata Critical Medical

According to the filing, Scott M. Wunsch, serving as CEO of Logistics at Strata Critical Medical, Inc., reported a series of transactions in Class A common stock, par value $0.0001 per share. Two RSU grants dated July 30, 2026, covering 9,787 and 2,658 shares respectively, were disclosed as quarterly commission program awards. The filing states that 100% of the 9,787-share grant will vest on September 8, 2026, and 100% of the 2,658-share grant will vest on December 8, 2026, each subject to the reporting person's continued service to the issuer.

On October 28, 2026, the filing reports that Wunsch acquired 57,173 shares and a further 57,173 shares upon the Compensation Committee's certification that performance criteria underlying a PSU award granted March 20, 2025 had been satisfied. A separate RSU grant of 1,416 shares, to vest March 8, 2027 under the quarterly commission program, was also reported on the same date. All acquisitions carried a price of $0.

Also on October 28, 2026, the filing reports a disposition coded "F" covering 44,996 shares at $4.76 per share, described as shares withheld by the issuer to satisfy tax withholding obligations in connection with PSU vesting. After all reported transactions, Wunsch's direct beneficial ownership stood at 746,254 shares. An additional 382,987 shares are held indirectly through a limited liability company of which Wunsch is the sole member, as noted in the filing's footnotes. The form was signed by Melissa M. Tomkiel as attorney-in-fact for Scott M. Wunsch.

What Was Disclosed

The filing disclosed RSU grants, PSU share settlements, and a tax-related share withholding for Scott M. Wunsch at Strata Critical Medical, Inc. (NASDAQ:SRTA), with Wunsch's direct beneficial ownership reported at 746,254 shares following all transactions.